Møller S - Search Results

1

Endothelin-1 and -3 plasma concentrations in patients with cirrhosis: role of splanchnic and renal passage and liver function.

Gerbes AL, Møller S, Gülberg V, Henriksen JH. Gerbes AL, et al. Among authors: moller s. Hepatology. 1995 Mar;21(3):735-9. Hepatology. 1995. PMID: 7875671

2

Assessment of response to beta-blockers by expression of βArr2 and RhoA/ROCK2 in antrum mucosa in cirrhotic patients.

Trebicka J, von Heydebrand M, Lehmann J, Tofteng F, Busk T, Jensen HL, Rohde J, Reiberger T, Mortensen C, Schierwagen R, Klein S, Møller S, Bendtsen F, Krag A. Trebicka J, et al. Among authors: moller s. J Hepatol. 2016 Jun;64(6):1265-73. doi: 10.1016/j.jhep.2016.01.022. Epub 2016 Jan 28. J Hepatol. 2016. PMID: 26827791

3

Does cardiac dysfunction explain deleterious effects of beta-blockers in cirrhosis and refractory ascites?

Krag A, Bendtsen F, Møller S. Krag A, et al. Among authors: moller s. Hepatology. 2011 Jan;53(1):370-1. doi: 10.1002/hep.23857. Epub 2010 Jul 29. Hepatology. 2011. PMID: 20815016 No abstract available.

4

Growth hormone binding protein in cirrhosis: normal or decreased?

Møller S, Fisker S, Becker U, Henriksen JH. Møller S, et al. J Hepatol. 2002 Nov;37(5):702-3. doi: 10.1016/s0168-8278(02)00273-8. J Hepatol. 2002. PMID: 12399243 No abstract available.

5

Cardiac output determined by echocardiography in patients with cirrhosis: comparison with the indicator dilution technique.

Andersen UB, Møller S, Bendtsen F, Henriksen JH. Andersen UB, et al. Among authors: moller s. Eur J Gastroenterol Hepatol. 2003 May;15(5):503-7. doi: 10.1097/01.meg.0000059106.41030.8e. Eur J Gastroenterol Hepatol. 2003. PMID: 12702907

6

Liver cirrhosis and arterial hypertension.

Henriksen JH, Moller S. Henriksen JH, et al. Among authors: moller s. World J Gastroenterol. 2006 Feb 7;12(5):678-85. doi: 10.3748/wjg.v12.i5.678. World J Gastroenterol. 2006. PMID: 16521178 Free PMC article. Review.

7

The royal free hospital cirrhosis glomerular filtration rate: Validation in a danish cohort.

Pedersen JS, Kimer N, Henriksen JH, Bendtsen F, Møller S. Pedersen JS, et al. Among authors: moller s. Hepatology. 2017 Oct;66(4):1360-1361. doi: 10.1002/hep.29386. Epub 2017 Aug 26. Hepatology. 2017. PMID: 28727168 No abstract available.

8

Assessment of systolic function in the evaluation of patients with cirrhosis.

Møller S, Hove JD. Møller S, et al. Hepatology. 2017 Jun;65(6):1799-1802. doi: 10.1002/hep.29163. Epub 2017 May 3. Hepatology. 2017. PMID: 28317147 No abstract available.

9

Terlipressin improves renal function in patients with cirrhosis and ascites without hepatorenal syndrome.

Krag A, Møller S, Henriksen JH, Holstein-Rathlou NH, Larsen FS, Bendtsen F. Krag A, et al. Among authors: moller s. Hepatology. 2007 Dec;46(6):1863-71. doi: 10.1002/hep.21901. Hepatology. 2007. PMID: 18027874 Clinical Trial.

10

Hypertension and liver disease.

Henriksen JH, Møller S. Henriksen JH, et al. Among authors: moller s. Curr Hypertens Rep. 2004 Dec;6(6):453-61. doi: 10.1007/s11906-004-0041-5. Curr Hypertens Rep. 2004. PMID: 15527691 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results